Literature DB >> 16289456

Investigation of hospital-acquired infections due to Achromobacter xylosoxidans in a tertiary care hospital in India.

A Kumar, P Ray, M Kanwar, S Sethi, A Narang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16289456     DOI： 10.1016/j.jhin.2005.07.016

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  5 in total

1.  Contamination of burn wounds by Achromobacter Xylosoxidans followed by severe infection: 10-year analysis of a burn unit population.

Authors:  A Schulz; W Perbix; P C Fuchs; H Seyhan; J L Schiefer
Journal:  Ann Burns Fire Disasters       Date:  2016-09-30

2.  Outbreak of Achromobacter xylosoxidans pseudobacteremia in a neonatal care unit related to contaminated chlorhexidine solution.

Authors:  J Molina-Cabrillana; C Santana-Reyes; A González-García; A Bordes-Benítez; I Horcajada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267

3.  Achromobacter spp. bacteremia outbreak related to contaminated furosemide ampoules.

Authors:  Rajalakshmi Arjun; Kalpana E John; Vettakkara Kandy Muhammed Niyas; Sreerekha R Nair; Viji Mohan; Raveendran Sarala Ratheesh
Journal:  Infez Med       Date:  2021-09-10

4.  Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.

Authors:  M Kaur; P Ray; M Bhatty; M Sharma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-17       Impact factor: 3.267

5.  Bacteremia due to Achromobacter xylosoxidans in neonates: clinical features and outcome.

Authors:  Ozden Turel; Sultan Kavuncuoglu; Emine Hosaf; Sibel Ozbek; Esin Aldemir; Turkan Uygur; Nevin Hatipoglu; Rengin Siraneci
Journal:  Braz J Infect Dis       Date:  2013-06-03       Impact factor: 3.257
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.